See all Profiles
Headshot photo of Muhammad J Habib
Faculty
Faculty

Muhammad J Habib

Associate Dean and Professor

  • Office of the Dean, Pharmacy
  • College of Pharmacy

Biography

Muhammad Jamil Habib, Ph.D. is the Associate Dean of Academic Affairs and professor at the Howard University College of Pharmacy. He has 28 years of experience in academia as educator, researcher and administrator. He is an ACPE trained accreditation evaluator and currently evaluating programs of several US pharmacy colleges. He has also developed and implemented pharmacy programs in Kuwait University. Presently, Habib is a tenured full professor serving as Associate Dean of Academic Affairs in the College of Pharmacy.

After receiving his Ph.D. in Pharmaceutical Sciences from the University of Alberta Canada in 1987 and training as research Associate at Florida A&M University in 1987-88, Habib joined Howard University, College of Pharmacy as faculty in 1988. He moved to Kuwait University, Faculty of Pharmacy in 1998 as Professor and Chairman. Habib returned to Howard University in July, 2000 and assumed the chairmanship of the department in 2002. He received several research grants from agencies like National Institute of Health (NIH), Parenteral Drug Administration, Pharmaceutical Companies and University Grant Programs which resulted in 141 publications and abstracts in peer-reviewed national and international journals. He has published books and contributed chapters in books. His research background is in formulation, drug delivery and dosage developments, process analytical technology (PAT) and quality by design (QBD). He has been invited to give scientific presentations to industries, government and professional organizations. Some of the topics of his presentations include, “Global Trend in Pharmacy Education”, “Transition from B.S. to Pharm.D. Education”, “Recent Advances in Drug Delivery System,” “Phospholipid Solid Dispersions: Physical Properties, Dissolution and Bioavailability”, “Pharmacy Education for the 21st century”, “Need for Professional Organizations in Pharmacy" etc. Habib taught several professional and graduate level courses including Advance Physical Pharmacy, Drug Development Strategies, Principles of Drug Formulation, Pharmaceutics, Dosage Form Design, Pharmaceutical Compounding, Pharmaceutical Technology etc. He has offered a refresher course on Pharmaceutical Drug Delivery to FDA scientists in Rockville, Maryland, USA.

Among many awards, he has received, the HU faculty author’s award, College of Pharmacy distinguished faculty service award and outstanding leadership award from AABPS are notable. He has served as a consultant on Pharm.D. curriculum nationally and internationally. Currently he is serving as a reviewer of professional research journals and as an editorial board member of a number of international journals including Journal of Pharmaceutical Technology, Pharmaceutics and Novel Drug Delivery System, Archives of Pharmacy Practice, Madridge Journal of Novel Drug Research, Omics journals of Pharmaceutical Sciences, Journal of Chemistry. He has served as a Chairman and member on various departmental, college and university committees including President’s Budget Advisory Committee, Long Range Planning Committee, University Wide Safety Committee, Graduate Program Evaluation Committee, Pharm.D. Program Implementation Committee, Curriculum Committee, Resource Allocation, Dean’s Search Committee etc.

Habib has received leadership training from the Covey Leadership Center, USA on the Seven Habits of Highly Effective People. He is a member of several professional organizations in North America including American Association of Pharmaceutical Scientists (AAPS), Controlled Release Society (CRS), American Association of Colleges of Pharmacy (AACP), Sigma Xi scientific research society, Rho Chi Honors Society and ACPE.

Education & Expertise

Education

Doctor of Philosophy (Ph.D.)

Pharmaceutical Science
University of Alberta, Edmonton, Alberta, Canada
1987

Master of Pharmacy (M.Pharm)

Pharmaceutics
University of Dhaka
1982

Bachelor of Pharmacy (B.Pharm)

Pharmacy
University of Dhaka
1980

Academics

Academics

Graduate Courses

Advance Physical Pharmacy

Drug Development Strategies

Principles of Drug Formulation

Special Topics

Research in Pharmaceutical Sciences

Professional Courses

Pharmaceutical Care I

Pharmaceutics

Pharmaceutical Mathematics

Physical Pharmacy

Pharmaceutical Science Laboratory

Pharmaceutical Technology & Lab

Pharmaceutical Dosage Form I

Pharmaceutical Dosage Form II

Dosage Form Design

Basic Pharmaceutics

Clinical Pharmacology/Pharmacy

Undergraduate Research in Pharmaceutics

Pharm.D. research in Pharmaceutic

Pharmaceutical Compounding Lab

Introduction to Pharmacy

Research

Research

Specialty

Stability and dissolution aspect of drug delivery system, Controlled drug delivery using novel techniques, Use of liposomes in drug delivery systems

Funding

Principal Investigator: RCMI Start-up Grant for a new faculty. US $150,452. Funded 2010-12

Program Director: Minority Faculty Fellowship Program (MFFP). Grant #2G12RR003048-23. National Institute of Health, $160,000. Direct cost, 2005-08. Funded.

Responsible for College of Pharmacy program: Undergraduate Students Access to Research Program (USTAR) of N.I.H. Dr. Arthur Williams as P.I., $233,954.00 from 06/01/97 through 5/31/00. (Advisory Council Member). Funded.

“Development and Characterization of a Subcutaneous Nanoformulation of Letrozole for Treatment of Breast Cancer”, Health sciences Faculty Seed Grant Program, $25,000. Funded. 2010.

Accomplishments

Accomplishments

National Register’s Who’s Who in Executives and Professionals, 2006-07

Publications and Presentations

Publications and Presentations

NAG-PEGylated multilamellar liposomes for BBB-GLUT transporter targeting

NAG-PEGylated multilamellar liposomes for BBB-GLUT transporter targeting

The primary objective of the research study is to investigate Glucose (GLUT) transporter targeting of the drug (Citalopram-Hbr) for increased permeability across the Blood-Brain Barrier (BBB). The current study reports the development, physicochemical characterization, cytotoxicity analysis and in-vitro BBB permeability assessment of the Citalopram-Hbr liposomal formulations.

Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery

Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: in vitro pharmaceutics and Caco-2 permeability investigations

Tenofovir, currently marketed as the prodrug tenofovir disoproxil fumarate, is used clinically to treat patients with HIV/AIDS. The oral bioavailability of tenofovir is relatively low, limiting its clinical effectiveness. Encapsulation of tenofovir within modified long-circulating liposomes would deliver this hydrophilic anti-HIV drug to the reticuloendothelial system for better therapeutic efficacy. The objectives of the current study were to prepare and pharmaceutically characterize model liposomal tenofovir formulations in an attempt to improve their bioavailability.

QbD approach to investigate product and process variabilities for brain targeting liposomes

QbD approach to investigate product and process variabilities for brain targeting liposomes

Efficacy of central nervous system-acting medications is limited by its localization and ability to cross the blood–brain barrier (BBB); therefore, the crux is in designing delivery systems targeted to cross the BBB. Toward this objective, this study proposed pegylated and glycosylated citalopram hydrobromide (Cit-HBr) liposomes as a delivery approach for brain targeting.

Maximized Mucoadhesion and Skin Permeation of Anti-AIDS-Loaded Niosomal Gels

Maximized Mucoadhesion and Skin Permeation of Anti-AIDS-Loaded Niosomal Gels

The low permeability of the anti-AIDS, tenofovir, limits its antiretroviral clinical potency. The proposed study aimed at assessing the critical biological responses of tenofovir through the development and optimization of its surfactant-based niosomal gels intended for vaginal delivery.